Pharmacological Mechanisms Underlying the Anti-asthmatic Effects of Modified Guomin Decoction Determined by Network Pharmacology and Molecular Docking
BackgroundAsthma is a chronic inflammatory disease characterized by Th2-predominant inflammation and airway remodeling. Modified Guo Min decoction (MGMD) has been an extensive practical strategy for allergic disorders in China. Although its potential anti-asthmatic activity has been reported, the ex...
Main Authors: | Guishu Wang, Bo Zhou, Zheyi Wang, Yufeng Meng, Yaqian Liu, Xiaoqin Yao, Cuiling Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.644561/full |
Similar Items
-
Pharmacological Rationale for Targeting IL-17 in Asthma
by: Siti Farah Rahmawati, et al.
Published: (2021-08-01) -
Preventive effects of donkey milk powder on the ovalbumin-induced asthmatic mice
by: Yao Lu, et al.
Published: (2021-09-01) -
Investigation of the active components and mechanism of Sanao Decoction in treating chronic cough by network pharmacology and molecular docking
by: Sheng Mengke, et al.
Published: (2021-09-01) -
Role of Platelet-Derived Growth Factor (PDGF) in Asthma as an Immunoregulatory Factor Mediating Airway Remodeling and Possible Pharmacological Target
by: Grzegorz Kardas, et al.
Published: (2020-02-01) -
Airway Remodeling in Asthma
by: Yuki Sumi, et al.
Published: (2007-01-01)